Аннотация:
This article discusses the utility of Xeomin for the treatment of rare hyperkinetic disorders in children. We demonstrated high therapeutic efficacy of botulinum toxin type A for severe pediatric dystonias, such as congenital muscular dystonia and Hallervorden-Spatz disease. In such cases, botulinum toxin therapy is the only possible option not only to correct and increase motor activity, but also to improve the quality of life of these patients and their families. © 2019, Dynasty Publishing House. All rights reserved.
Ключевые слова:
Botulinum toxin type A; Children; Muscular dystonia
botulinum toxin A; Article; drug efficacy; dystonia; human; motor activity; neurodegeneration with brain iron accumulation; quality of life
Хачатрян Л. Г. Лусине Грачиковна 1969-
Лялина А. А. Анастасия Андреевна 1992-
Зотова Н. С. Нелли Сергеевна 1980-
Куренков А. Л.
Ахадова Л. Y.
Быкова О. В. Ольга Владимировна 1972-
Khachatryan L. G. Lusine Grachikovna 1969-
Lyalina A. A. Anastasiya Andreevna 1992-
Zotova N. S. Nelli Sergeevna 1980-
Kurenkov A. L.
Akhadova L. Y.
By'kova O. V. Ol`ga Vladimirovna 1972-
Efficacy of botulinum toxin type A in children with muscular dystonia
Текст визуальный непосредственный
Вопросы практической педиатрии
ООО "Издательство "Династия"
Т. 14, Вып. 3 С. 58-67
2019
Статья
Botulinum toxin type A Children Muscular dystonia
botulinum toxin A Article drug efficacy dystonia human motor activity neurodegeneration with brain iron accumulation quality of life
This article discusses the utility of Xeomin for the treatment of rare hyperkinetic disorders in children. We demonstrated high therapeutic efficacy of botulinum toxin type A for severe pediatric dystonias, such as congenital muscular dystonia and Hallervorden-Spatz disease. In such cases, botulinum toxin therapy is the only possible option not only to correct and increase motor activity, but also to improve the quality of life of these patients and their families. © 2019, Dynasty Publishing House. All rights reserved.